Literature DB >> 16140007

Risks of second primary breast and urogenital cancer following female breast cancer in the south of The Netherlands, 1972-2001.

I Soerjomataram1, W J Louwman, V E P P Lemmens, E de Vries, W J Klokman, J W W Coebergh.   

Abstract

A cohort of 9919 breast cancer patients from the population-based Eindhoven Cancer Registry was followed for vital status and development of second cancer. Person-year analysis was applied to determine the risk of second primary breast or urogenital cancer among breast cancer patients and to assess its correlation with age, treatment and time since the first breast cancer diagnosis. Women with previous breast cancer have an elevated risk of overall second breast or urogenital cancer. The largest relative risk was observed for second breast cancer (SIR (standardised incidence ratio) 3.5; 95% confidence interval (CI) 3.2-3.8) and second ovarian cancer (SIR 1.7; 95% CI 1.2-2.3). The absolute excess risk was highest for second breast cancer (64/10,000 patients/year). However, breast cancer has an inverse relationship to risk of cervical cancer. Changes in behavioural risk factors are important for lowering the risk of second cancer after breast cancer.

Entities:  

Mesh:

Year:  2005        PMID: 16140007     DOI: 10.1016/j.ejca.2005.01.029

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  14 in total

1.  Serum antioxidant capacity, biochemical profile and body composition of breast cancer survivors in a randomized Mediterranean dietary intervention study.

Authors:  Maria Skouroliakou; D Grosomanidis; P Massara; C Kostara; P Papandreou; D Ntountaniotis; G Xepapadakis
Journal:  Eur J Nutr       Date:  2017-06-20       Impact factor: 5.614

2.  Synchronous and metachronous bilateral breast cancer: a long-term single-institution experience.

Authors:  Robert Díaz; Blanca Munárriz; Ana Santaballa; Laura Palomar; Joaquín Montalar
Journal:  Med Oncol       Date:  2010-12-31       Impact factor: 3.064

3.  PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients.

Authors:  Daniele Giardiello; Maartje J Hooning; Michael Hauptmann; Renske Keeman; B A M Heemskerk-Gerritsen; Heiko Becher; Carl Blomqvist; Stig E Bojesen; Manjeet K Bolla; Nicola J Camp; Kamila Czene; Peter Devilee; Diana M Eccles; Peter A Fasching; Jonine D Figueroa; Henrik Flyger; Montserrat García-Closas; Christopher A Haiman; Ute Hamann; John L Hopper; Anna Jakubowska; Floor E Leeuwen; Annika Lindblom; Jan Lubiński; Sara Margolin; Maria Elena Martinez; Heli Nevanlinna; Ines Nevelsteen; Saskia Pelders; Paul D P Pharoah; Sabine Siesling; Melissa C Southey; Annemieke H van der Hout; Liselotte P van Hest; Jenny Chang-Claude; Per Hall; Douglas F Easton; Ewout W Steyerberg; Marjanka K Schmidt
Journal:  Breast Cancer Res       Date:  2022-10-21       Impact factor: 8.408

4.  Surveillance mammography among female Department of Defense beneficiaries: a study by race and ethnicity.

Authors:  Lindsey Enewold; Katherine A McGlynn; Shelia H Zahm; Ismail Jatoi; William F Anderson; Abegail A Gill; Craig D Shriver; Kangmin Zhu
Journal:  Cancer       Date:  2013-08-01       Impact factor: 6.860

5.  Second non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study Group.

Authors:  Lorenzo Gianni; Shari Gelber; Alberto Ravaioli; Karen N Price; Ilaria Panzini; Manuela Fantini; Monica Castiglione-Gertsch; Olivia Pagani; Edda Simoncini; Richard D Gelber; Alan S Coates; Aron Goldhirsch
Journal:  Eur J Cancer       Date:  2008-12-04       Impact factor: 9.162

6.  Increased risk of second malignancies after in situ breast carcinoma in a population-based registry.

Authors:  I Soerjomataram; W J Louwman; M J C van der Sangen; R M H Roumen; J W W Coebergh
Journal:  Br J Cancer       Date:  2006-06-27       Impact factor: 7.640

7.  The impact of disease progression on perceived health status and quality of life of long-term cancer survivors.

Authors:  Melissa S Y Thong; Floortje Mols; Jan-Willem W Coebergh; Jan A Roukema; Lonneke V van de Poll-Franse
Journal:  J Cancer Surviv       Date:  2009-06-26       Impact factor: 4.442

8.  Relation of risk of contralateral breast cancer to the interval since the first primary tumour.

Authors:  C Rubino; R Arriagada; S Delaloge; M G Lê
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640

9.  Rising incidence of breast cancer among female cancer survivors: implications for surveillance.

Authors:  I Soerjomataram; W J Louwman; L E M Duijm; J W W Coebergh
Journal:  Br J Cancer       Date:  2008-12-09       Impact factor: 7.640

10.  Synchronous and metachronous breast malignancies: a cross-sectional retrospective study and review of the literature.

Authors:  Ambrogio P Londero; Sergio Bernardi; Serena Bertozzi; Vito Angione; Giuliana Gentile; Cinzia Dri; Antonio Minucci; Filippo Caponnetto; Roberto Petri
Journal:  Biomed Res Int       Date:  2014-04-27       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.